Dear Readers,
As the editorial board of Forbes Journal of Medicine, we are delighted to present the 2026 editorial of our journal with increasing excitement and motivation after our sixth year of publication. In the past year, a total of 39 scientific studies were published in our journal in the fields of Medicine and Health Sciences, including 3 review articles, 34 original research articles, and 2 case reports. As a result of the publication evaluation and printing processes meticulously carried out by the Forbes Journal of Medicine Editorial Board since the first issue, our journal continues to be indexed in our national index ULAKBİM (TR Dizin), Turkish Citation Index, and Turkish Medline, which have a very important place in academic publishing, as well as in international academic indexes such as EBSCO, J-Gate, GALE, and DOAJ. In addition, as of the past year, our journal has also taken its place in the prestigious international indexes Embase, EmCare, and EmBiology. We would like to share that, in line with our goal of further strengthening our journal and achieving success, especially internationally, we are continuing our application process to important international indexes, primarily ESCI and SCOPUS.
As Forbes Journal of Medicine, we closely follow current developments in scientific publication processes, and in this regard, we would like to share that as of the 2026 publication year, our journal will be published only in English and will have transitioned to a continuous publication model. We would like to express our sincere gratitude to the authors who submitted their work to our journal, to the editors and advisory board members who evaluated them, and to our reviewers.
Sincerely,
Professor M. Yekta ÖNCEL, MD
Editor in Chief
